The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Bevacizumab
Australian Public Assessment Report
Device/Product Name
Abevmy
Active ingredients
Bevacizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-01736-1-4
Submission Type
New biosimilar medicine
Decision
Approved